NBIX Exercise Disclosure
Gano Kyle · SEC Form 4 · Filed Nov 3, 2026
Exercise
Calculated transaction value
$0
Gano Kyle Chief Executive Officer
NBIX
Transaction date
Nov 1, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 2 days later
NBIX daily price context
Close on/before transaction
$146.1
Oct 30, 2026
First close after public filing
$166.05
Nov 4, 2026
Return after filing · so far
-0.86%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 614 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001567160-26-000011
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$48.51K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Neurocrine Biosciences Inc NBIX | Disposition | Nov 1, 2026 | $48.51K |
| Neurocrine Biosciences Inc NBIX Current | Exercise | Nov 1, 2026 | $0 |
| Neurocrine Biosciences Inc NBIX | Exercise | Nov 1, 2026 | $0 |